Atara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting

Press/Media: Press / Media

PeriodMay 15 2019 → May 16 2019

Media coverage

7

Media coverage

  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletPlus Company Updates (PCU)
    CountryUnited States
    Date5/16/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletMorningstar.com
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletTMC Net
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletYahoo! Finance
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletPrimeNewswire (Top News)
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz
  • TitleAtara Biotherapeutics Announces Presentations Highlighting Tab-cel® and Mesothelin-Targeted CAR T Clinical Results at American Society of Clinical Oncology (ASCO) Annual Meeting
    Media name/outletGlobeNewswire
    CountryUnited States
    Date5/15/19
    PersonsMissak Haigentz